These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 28974225)

  • 1. Metal nanoparticles: understanding the mechanisms behind antibacterial activity.
    Slavin YN; Asnis J; Häfeli UO; Bach H
    J Nanobiotechnology; 2017 Oct; 15(1):65. PubMed ID: 28974225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity.
    Durán N; Durán M; de Jesus MB; Seabra AB; Fávaro WJ; Nakazato G
    Nanomedicine; 2016 Apr; 12(3):789-799. PubMed ID: 26724539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activities of transient metals nanoparticles and membranous mechanisms of action.
    Gabrielyan L; Trchounian A
    World J Microbiol Biotechnol; 2019 Oct; 35(10):162. PubMed ID: 31612285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Molecular Mechanisms of the Antibacterial Effect of Picosecond Laser Generated Silver Nanoparticles and Their Toxicity to Human Cells.
    Korshed P; Li L; Liu Z; Wang T
    PLoS One; 2016; 11(8):e0160078. PubMed ID: 27575485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future prospects of antibacterial metal nanoparticles as enzyme inhibitor.
    Ahmed KBA; Raman T; Veerappan A
    Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():939-947. PubMed ID: 27524096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli.
    Cui Y; Zhao Y; Tian Y; Zhang W; Lü X; Jiang X
    Biomaterials; 2012 Mar; 33(7):2327-33. PubMed ID: 22182745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial mechanism of silver nanoparticles in Pseudomonas aeruginosa: proteomics approach.
    Yan X; He B; Liu L; Qu G; Shi J; Hu L; Jiang G
    Metallomics; 2018 Apr; 10(4):557-564. PubMed ID: 29637212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism and targets of the antimicrobial activity of metal nanoparticles.
    Oktar FN; Yetmez M; Ficai D; Ficai A; Dumitru F; Pica A
    Curr Top Med Chem; 2015; 15(16):1583-8. PubMed ID: 25877090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Gold Nanoclusters.
    Zheng K; Setyawati MI; Leong DT; Xie J
    ACS Nano; 2017 Jul; 11(7):6904-6910. PubMed ID: 28595000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimetallic Nanoparticles as Alternative Antimicrobial Agents: Challenges and Perspectives.
    Basavegowda N; Baek KH
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33572219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial Activity and Mechanisms of Action of Inorganic Nanoparticles against Foodborne Bacterial Pathogens: A Systematic Review.
    Girma A; Abera B; Mekuye B; Mebratie G
    IET Nanobiotechnol; 2024; 2024():5417924. PubMed ID: 38863967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and challenges in bacterial infection theranostics based on functional metal nanoparticles.
    Guo Z; Jiang H; Song A; Liu X; Wang X
    Adv Colloid Interface Sci; 2024 Oct; 332():103265. PubMed ID: 39121833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding and overcoming antibiotic resistance.
    Richardson LA
    PLoS Biol; 2017 Aug; 15(8):e2003775. PubMed ID: 28832581
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymol-Decorated Gold Nanoparticles for Curing Clinical Infections Caused by Bacteria Resistant to Last-Resort Antibiotics.
    Huang Z; Zhang X; Yao Z; Han Y; Ye J; Zhang Y; Chen L; Shen M; Zhou T
    mSphere; 2023 Jun; 8(3):e0054922. PubMed ID: 37017551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities.
    Khorsandi K; Hosseinzadeh R; Sadat Esfahani H; Keyvani-Ghamsari S; Ur Rahman S
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1299-1323. PubMed ID: 33755503
    [No Abstract]   [Full Text] [Related]  

  • 18. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antibacterial effect of copper and silver nanoparticles and their mechanism of action.
    Vasiliev G; Kubo AL; Vija H; Kahru A; Bondar D; Karpichev Y; Bondarenko O
    Sci Rep; 2023 Jun; 13(1):9202. PubMed ID: 37280318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyroelectric Janus nanomotors for synergistic electrodynamic-photothermal-antibiotic therapies of bacterial infections.
    Meng J; Zhang P; Liu Q; Ran P; Xie S; Wei J; Li X
    Acta Biomater; 2023 May; 162():20-31. PubMed ID: 36931421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.